Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
    • Author Policies
    • Manuscript Submission Guidelines
  • About Us
    • About AJNR
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Podcasts
    • Subscribe on iTunes
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
    • Author Policies
    • Manuscript Submission Guidelines
  • About Us
    • About AJNR
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Podcasts
    • Subscribe on iTunes
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research ArticleBRAIN

Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?

S. Bisdas, M. Kirkpatrick, P. Giglio, C. Welsh, M.V. Spampinato and Z. Rumboldt
American Journal of Neuroradiology April 2009, 30 (4) 681-688; DOI: https://doi.org/10.3174/ajnr.A1465
S. Bisdas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kirkpatrick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Giglio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Welsh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.V. Spampinato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z. Rumboldt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Current classification and grading of primary brain tumors has significant limitations. Our aim was to determine whether the relative cerebral volume (rCBV) measurements in gliomas may serve as an adjunct to histopathologic grading, with a hypothesis that rCBV values are more accurate in predicting 1-year survival and recurrence.

MATERIALS AND METHODS: Thirty-four patients with gliomas (WHO grade I-IV, 27 astrocytomas, 7 tumors with oligodendroglial components) underwent contrast-enhanced MR rCBV measurements before treatment. The region of interest and the single pixel with the maximum CBV value within the tumors were normalized relative to the contralateral normal tissue (rCBVmean and rCBVmax, respectively). Karnofsky performance score and progression-free survival (PFS) were recorded. Receiver operating characteristic curves and Kaplan-Meier survival analysis were conducted for CBV and histologic grade (WHO grade).

RESULTS: Significant correlations were detected only when patients with oligodendrogliomas and oligoastrocytomas were excluded. The rCBVmean and rCBVmax in the astrocytomas were 3.5 ± 2.9 and 3.7 ± 2.7. PFS correlated with rCBV parameters (r = −0.54 to −0.56, P ≤ .009). WHO grade correlated with rCBV values (r = 0.65, P ≤ .0002). rCBVmax >4.2 was found to be a significant cutoff value for recurrence prediction with 77.8% sensitivity and 94.4% specificity (P = .0001). rCBVmax ≤3.8 was a significant predictor for 1-year survival (93.7% sensitivity, 72.7% specificity, P = .0002). The relative risk for shorter PFS was 11.1 times higher for rCBVmax >4.2 (P = .0006) and 6.7 times higher for WHO grade >II (P = .05). The combined CBV−WHO grade classification enhanced the predictive value for recurrence/progression (P < .0001).

CONCLUSIONS: rCBV values in astrocytomas but not tumors with oligodendroglial components are predictive for recurrence and 1-year survival and may be more accurate than histopathologic grading.

  • Copyright © American Society of Neuroradiology
View Full Text
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 30 (4)
American Journal of Neuroradiology
Vol. 30, Issue 4
April 2009
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
S. Bisdas, M. Kirkpatrick, P. Giglio, C. Welsh, M.V. Spampinato, Z. Rumboldt
American Journal of Neuroradiology Apr 2009, 30 (4) 681-688; DOI: 10.3174/ajnr.A1465

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
S. Bisdas, M. Kirkpatrick, P. Giglio, C. Welsh, M.V. Spampinato, Z. Rumboldt
American Journal of Neuroradiology Apr 2009, 30 (4) 681-688; DOI: 10.3174/ajnr.A1465
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance
  • MR Imaging Features of Anaplastic Pleomorphic Xanthoastrocytoma Mimicking High-Grade Astrocytoma
  • Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression
  • Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas
  • ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the Brain
  • Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas
  • MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II-IV Astrocytomas
  • Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
  • Role of MRI in Primary Brain Tumor Evaluation
  • Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
  • Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging Variables
  • Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study
  • Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
  • Quantitative Blood Flow Measurements in Gliomas Using Arterial Spin-Labeling at 3T: Intermodality Agreement and Inter- and Intraobserver Reproducibility Study
  • The Holy Grail and the Quest for the Gold Standard
  • Switching on the Lights for Real-Time Multimodality Tumor Neuroimaging: The Integrated Positron-Emission Tomography/MR Imaging System
  • Crossref (95)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the Brain
    K. Welker, J. Boxerman, A. Kalnin, T. Kaufmann, M. Shiroishi, M. Wintermark
    American Journal of Neuroradiology 2015 36 6
  • A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
    Xing Liu, Yiming Li, Zenghui Qian, Zhiyan Sun, Kaibin Xu, Kai Wang, Shuai Liu, Xing Fan, Shaowu Li, Zhong Zhang, Tao Jiang, Yinyan Wang
    NeuroImage: Clinical 2018 20
  • Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
    Nathalie L. Jansen, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Andrei Todica, Sabina Eigenbrod, Maximilian Niyazi, Jörg-Christian Tonn, Peter Bartenstein, Friedrich-Wilhelm Kreth, Christian la Fougère
    Journal of Nuclear Medicine 2015 56 1
  • Medical Image Computing and Computer-Assisted Intervention – MICCAI 2016
    Dong Nie, Han Zhang, Ehsan Adeli, Luyan Liu, Dinggang Shen
    2016 9901
  • Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
    Nathalie L. Jansen, Bogdana Suchorska, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Mark Drexler, Peter Bartenstein, Oliver Schnell, Jörg-Christian Tonn, Niklas Thon, Friedrich-Wilhelm Kreth, Christian la Fougère
    Journal of Nuclear Medicine 2014 55 2
  • Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers
    Rajan Jain, Laila Poisson, Jayant Narang, David Gutman, Lisa Scarpace, Scott N. Hwang, Chad Holder, Max Wintermark, Rivka R. Colen, Justin Kirby, John Freymann, Daniel J. Brat, Carl Jaffe, Tom Mikkelsen
    Radiology 2013 267 1
  • Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
    L.S. Hu, J.M. Eschbacher, A.C. Dueck, J.E. Heiserman, S. Liu, J.P. Karis, K.A. Smith, W.R. Shapiro, D.S. Pinnaduwage, S.W. Coons, P. Nakaji, J. Debbins, B.G. Feuerstein, L.C. Baxter
    American Journal of Neuroradiology 2012 33 1
  • Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
    N. L. Jansen, C. Schwartz, V. Graute, S. Eigenbrod, J. Lutz, R. Egensperger, G. Popperl, H. A. Kretzschmar, P. Cumming, P. Bartenstein, J.-C. Tonn, F.-W. Kreth, C. la Fougere, N. Thon
    Neuro-Oncology 2012 14 12
  • Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans
    Nathalie L. Albert, Isabel Winkelmann, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Erik Mille, Andrei Todica, Matthias Brendel, Jörg-Christian Tonn, Peter Bartenstein, Christian la Fougère
    European Journal of Nuclear Medicine and Molecular Imaging 2016 43 6
  • A Generic Support Vector Machine Model for Preoperative Glioma Survival Associations
    Kyrre E. Emblem, Marco C. Pinho, Frank G. Zöllner, Paulina Due-Tonnessen, John K. Hald, Lothar R. Schad, Torstein R. Meling, Otto Rapalino, Atle Bjornerud
    Radiology 2015 275 1

More in this TOC Section

  • Multimodal CT Provides Improved Performance for Lacunar Infarct Detection
  • Optimal MRI Sequence for Identifying Occlusion Location in Acute Stroke: Which Value of Time-Resolved Contrast-Enhanced MRA?
  • Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers

Resources

  • Evidence-Based Medicine Level Guide
  • AJNR Podcast Archive
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Get Peer Review Credit from Publons

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire